Inovio Pharmaceuticals(INO) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Inovio Pharmaceuticals' Earnings Call: Progress Amid Challenges
TipRanksMar 21 20:04 ET
Inovio Pharmaceuticals Inc. Stock Slips 6.7%, Underperforms Competitors
Dow JonesMar 19 16:33 ET
H.C. Wainwright Initiates Inovio Pharmaceuticals(INO.US) With Hold Rating, Announces Target Price $3
Moomoo NewsMar 19 13:31 ET · Ratings
RBC Capital Maintains Inovio Pharmaceuticals(INO.US) With Hold Rating, Cuts Target Price to $5
Moomoo NewsMar 19 13:31 ET · Ratings
Inovio Pharma Is Maintained at Sector Perform by RBC Capital
Dow JonesMar 19 10:46 ET · Ratings
Inovio Aims for INO-3107 Regulatory Submission by Mid-2025 While Addressing Key Manufacturing Issues
Seeking AlphaMar 19 08:26 ET

Comments

Teddy123

Mar 19 08:41

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

$Inovio Pharmaceuticals (INO.US)$
INOVIO Slashes Losses by $28M as RRP Treatment Shows 50% Complete Response Rate

Teddy123

Mar 14 13:17

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

$Inovio Pharmaceuticals (INO.US)$
INOVIO's Revolutionary COVID-19 Antibody Treatment Maintains 100% Efficacy for 72 Weeks

Jaguar8

Mar 14 06:30

🟡Watchlist, MARCH 14,2025, Friday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you...

28

17

3

Jaguar8

Mar 14 06:15

NEWS

$Inovio Pharmaceuticals (INO.US)$
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
Thursday, 13th March at 6:15 pm
• Long-lasting in vivo antibody production: DMAb levels remained stable for 72 weeks in all participants (n=24) who have reached that timepoint
• No anti-drug antibodies (ADA): no immune rejection of the DMAbs was detected across ~1,000 blood samples, unlike other gene-based antibod...

1

Lnova

Feb 23 05:34

Phase 1/2 Data to be Presented Feb 23-26

$Inovio Pharmaceuticals (INO.US)$
“Phase 1/2 data due to be presented at AACR-IO on February 23-26, 2025. BLA submission due in mid-2025. New immunology on Phase 1/2 data shows INO-3107 induced an expansion of new clonal T cells in blood that were not detectable prior to treatment, noted November 13, 2024.”
｡ﾟ* ҉* ੈ‧₊ ｡ﾟnot financial advice

1

INO Inovio Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Market Insights